Revenue growth in the first half FY22 was good because last year was poor (down 11%) because of Covid etc.
H1 FY21 − The lower revenue was primarily driven by the foreshadowed reduction in purchases by GE Healthcare as a result of the impacts of COVID-19 on its inventory at 30 June 2020 as well as the impact of a stronger Australian dollar.
Revenue growth in the first half FY22 was good because last year...
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.49 |
Change
-0.050(1.41%) |
Mkt cap ! $1.063B | |||
| Open | High | Low | Value | Volume |
| $3.57 | $3.58 | $3.44 | $1.164M | 333.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 768 | $3.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.50 | 9549 | 25 |
View Market Depth
| Last trade - 13.13pm 13/09/2024 (20 minute delay) ? |
| NAN (ASX) Chart |